Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A single-cell lung atlas of complement genes identifies the mesothelium and epithelium as prominent sources of extrahepatic complement proteins. | Mucosal Immunol | 2022 | 35672453 | PubTator, text mining | PubMed |
| SIRT2 functions as a histone delactylase and inhibits the proliferation and migration of neuroblastoma cells. | Cell Discov | 2022 | 35672301 | PubTator, text mining | PubMed |
| Plasma Kallikrein Cleaved H-kininogen: An End-Point Marker for Contact Activation in vitro and ex vivo. | Front Cardiovasc Med | 2022 | 35669477 | PubTator, text mining | PubMed |
| Component 1 Inhibitor Missense (Val480Met) Variant Is Associated With Gene Expression and Sepsis Development in Neonatal Lung Disease. | Front Pediatr | 2022 | 35669402 | PubTator, text mining | PubMed |
| A Systematic Framework for Identifying Prognostic Genes in the Tumor Microenvironment of Colon Cancer. | Front Oncol | 2022 | 35664768 | PubTator, text mining | PubMed |
| Omics Biomarkers for Monitoring Tuberculosis Treatment: A Mini-Review of Recent Insights and Future Approaches. | Infect Drug Resist | 2022 | 35664683 | PubTator, text mining | PubMed |
| Artificial neural networks enable genome-scale simulations of intracellular signaling. | Nat Commun | 2022 | 35654811 | PubTator, text mining | PubMed |
| Icatibant use in Brazilian patients with hereditary angioedema (HAE) type 1 or 2 and HAE with normal C1-INH levels: findings from the Icatibant Outcome Survey Registry Study. | An Bras Dermatol | 2022 | 35654647 | PubTator, text mining | PubMed |
| Orphan Drug Use in Patients With Rare Diseases: A Population-Based Cohort Study. | Front Pharmacol | 2022 | 35652051 | PubTator, text mining | PubMed |
| Novel interaction of properdin and coagulation factor XI: Crosstalk between complement and coagulation. | Res Pract Thromb Haemost | 2022 | 35647477 | PubTator, text mining | PubMed |
| Key Genes Identified in Nonsyndromic Microtia by the Analysis of Transcriptomics and Proteomics. | ACS Omega | 2022 | 35647449 | PubTator, text mining | PubMed |
| Insights on Proteomics-Driven Body Fluid-Based Biomarkers of Cervical Cancer. | Proteomes | 2022 | 35645371 | PubTator, text mining | PubMed |
| Using plasma proteomics to investigate viral infections of the central nervous system including patients with HIV-associated neurocognitive disorders. | J Neurovirol | 2022 | 35639337 | PubTator, text mining | PubMed |
| Machine Learning for the Identification of a Common Signature for Anti-SSA/Ro 60 Antibody Expression Across Autoimmune Diseases. | Arthritis Rheumatol | 2022 | 35635731 | PubTator, text mining | PubMed |
| Development of New Drugs for Autoimmune Hemolytic Anemia. | Pharmaceutics | 2022 | 35631621 | PubTator, text mining | PubMed |
| Proteomics Studies in Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis. | J Clin Med | 2022 | 35628864 | PubTator, text mining | PubMed |
| Benefits and Harms of Treatment and Preventive Interventions for Hereditary Angioedema: Protocol for a Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. | Genes (Basel) | 2022 | 35627309 | PubTator, text mining | PubMed |
| A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge. | PLoS Negl Trop Dis | 2022 | 35622847 | PubTator, text mining | PubMed |
| Contrasting behavior between the three human monocyte subsets in dengue pathophysiology. | iScience | 2022 | 35620424 | PubTator, text mining | PubMed |
| Macroglossia Associated With Clobazam Administration: A Case Report and Literature Review. | Front Neurol | 2022 | 35614921 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=50